Enbrel Articles
Immunex's Enbrel promise in psoriatic arthritis
10 August 2000
AHP posts healthy 2nd quarter results
24 July 2000
Stock Commentary New York
22 June 2000
Stock Commentary New York
8 June 2000
Nuvance trial data cause Immunex stutter
30 May 2000
AHP posts 18% net income growth
20 April 2000
Immunex' Enbrel backed for additional indications
13 April 2000
Serono "almost perfect biotech investment"
10 March 2000
Stock Commentary New York
10 February 2000
Enbrel gains Euro approval for arthritis
8 February 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
Enbrel selling at $500 million per year
6 December 1999
Centocor files for RA Remicade indication
21 October 1999
Stock Commentary New York
23 September 1999
Centocor unblinds Remicade RA trial
22 September 1999
Dynavax looks to IPO in 2000 to progress DNA immunization
16 September 1999
Stock Commentary New York
19 August 1999
Immunex' Enbrel in psoriatic arthritis
19 August 1999
Centocor expects Remicade decision in November
17 August 1999
Stock Commentary New York
17 June 1999
Stock Commentary New York
20 May 1999
Stock Commentary New York
29 April 1999
Stock Commentary New York
22 April 1999
Stock Commentary New York
31 March 1999
Enbrel to enter Phase II/III for heart failure
11 March 1999
Centocor files for Remicade in arthritis
27 January 1999
Stock Commentary New York
20 January 1999
Immunex Hit By Analyst Report On Enbrel Side Effects
16 December 1998
Enbrel Filed For Pediatric RA
2 December 1998
Stock Commentary New York
26 November 1998
FDAMA Fast-Track Development Proposals
23 November 1998
Centocor Shares Fall As Remicade Warning Goes Out
23 November 1998
Stock Commentary New York
19 November 1998
Remicade Effective In Rheumatoid Arthritis
11 November 1998
Immunex' Enbrel Launched In USA For Arthritis
3 November 1998
The Emerging Role Of Anticytokine Therapy
1 October 1998
Enbrel Recommended For Approval By US Panel
21 September 1998
Enbrel Recommended To FDA
17 September 1998
US Review Date Set For Immunex' Enbrel
6 August 1998
AHP Looks To Bright Future With New Products
30 April 1998
Immunex' Nuvance, Study Findings
19 March 1998
Product News In Brief
12 March 1998
Stock Commentary New York
12 February 1998
Cypress' Prosorba Effective In Rheumatoid Arthritis
29 January 1998
US Biotech Ends Year "Slightly Ahead" Of 1996
21 January 1998
Immunex' TNFR:Fc Offers New Approach To CHF
18 November 1997
US 3rd Quarter Results Show Strong Growth
22 October 1997
New York Stock Comment
16 October 1997
Roche Terminates Tenefuse For RA
16 October 1997
Stock Comment New York
2 October 1997
Boost For Immunex From AHP Deal
29 September 1997
Immunex Shares Soar On Enbrel Data
16 September 1997
Enbrel Effective In Arthritis, Says Study
23 July 1997
Stock Commentary New York
26 June 1997
Immunex' Enbrel Safe Over Long-Term Use
19 June 1997
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
